4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-18-062266
COO and Secretary sold 7,500 shares at an average $20.40 ($153,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COO and Secretary | 2018-12-10 | Sale | −2,500 | $20.18 | $50,450 | 682,589 | I: show line 1 in the form |
| Schuth Alexander O. COO and Secretary | 2018-12-11 | Sale | −2,500 | $20.22 | $50,550 | 680,089 | I: show line 2 in the form |
| Schuth Alexander O. COO and Secretary | 2018-12-12 | Sale | −2,500 | $20.80 | $52,000 | 677,589 | I: show line 3 in the form |
| Open-market sales · 7,500 sh · avg $20.40 · $153,000 | |||||||
Loading xslF345X03/doc4.xml…